These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 379336)

  • 1. Orally active esters of cephalosporin antibiotics. 3. Synthesis and biological properties of aminoacyloxymethyl esters of 7-[D(-)-mandelamido]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-3-cephem-4-carboxylic acid.
    Wheeler WJ; Preston DA; Wright WE; Huffman GW; Osborne HE; Howard DP
    J Med Chem; 1979 Jun; 22(6):657-61. PubMed ID: 379336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally active esters of cephalosporin antibiotics. Synthesis and biological properties of acyloxymethyl esters of 7-(D-2-amino-2-phenylacetamido)-3-[5-methyl-(1,3,4-thiadiazol-2-yl)thiomethyl]-3-cephem-4-carboxylic acid.
    Wheeler WJ; Wright WE; Line VD; Froggé JA
    J Med Chem; 1977 Sep; 20(9):1159-64. PubMed ID: 21963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally active esters of cephalosporin antibiotics. II. Synthesis and biological properties of the acetoxymethyl ester of cefamandole.
    Wright WE; Wheeler WJ; Line VD; Frogge JA; Finley DR
    J Antibiot (Tokyo); 1979 Nov; 32(11):1155-60. PubMed ID: 528384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KY-109, a new bifunctional pro-drug of a cephalosporin. Chemistry, physico-chemical and biological properties.
    Kakeya N; Nishizawa S; Nishimura K; Yoshimi A; Tamaki S; Mori T; Kitao K
    J Antibiot (Tokyo); 1985 Mar; 38(3):380-9. PubMed ID: 3839226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on orally active cephalosporin pro-drug. Synthesis, oral absorption and antibacterial activity of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 7-[D-O-(aminoacyl)mandelamido]-3-[[(5-methyl-1,3,4-thiadiazol -2-yl)-thio]methyl]-3-cephem-4-carboxylates].
    Nishizawa S; Yoshimi A; Muro H; Kasai M; Hatano S; Hashizume H; Yamada T; Hashimoto E; Nishimura K; Kakeya N
    Yakugaku Zasshi; 1988 Aug; 108(8):745-53. PubMed ID: 3246644
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on orally active cephalosporin esters.
    Fujimoto K; Ishihara S; Yanagisawa H; Ide J; Nakayama E; Nakao H; Sugawara S; Iwata M
    J Antibiot (Tokyo); 1987 Mar; 40(3):370-84. PubMed ID: 3570989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefamandole: pharmacokinetics and therapeutic evaluation in urology.
    Zinati AH; Naber KG
    Arzneimittelforschung; 1980; 30(5):839-42. PubMed ID: 7190432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of a new semisynthetic cephalosporin, CN-92,982.
    Mich TF; Huang GG; Woo PW; Sanchez JP; Heifetz CL; Schweiss D; Krolls U; Hutt MP; Chlbertson TP; Haskell TH
    J Antibiot (Tokyo); 1980 Nov; 33(11):1352-6. PubMed ID: 7251474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally active cephalosporins. III. Synthesis and structure-activity relationships of new 3-heterocyclicthiomethylthio-7 beta-[(Z)- 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-cephem-4 -carboxylic acids.
    Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K
    J Antibiot (Tokyo); 1993 Feb; 46(2):316-30. PubMed ID: 8468248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of a new cephalosporin, BMY-28232 and its prodrug-type esters for oral use.
    Kamachi H; Narita Y; Okita T; Abe Y; Iimura S; Tomatsu K; Yamasaki T; Okumura J; Naito T; Oki T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1602-16. PubMed ID: 3198494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally absorbable D-forphenicinol-cephalosporins.
    Koyama Y; Huang SP; Ikeda D; Hamada M; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jun; 42(6):993-9. PubMed ID: 2737957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of 1-acyloxyethyl esters of 7-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoe thy l)-1H-tetrazol-5-yl]thio]-methyl]ceph-3-em-4-carboxylic acid (cefotiam) and their oral absorption in mice.
    Yoshimura Y; Hamaguchi N; Yashiki T
    J Antibiot (Tokyo); 1986 Sep; 39(9):1329-42. PubMed ID: 3465717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on prodrugs of cephalosporins. I. Synthesis and biological properties of glycyloxybenzoyloxymethyl and glycylaminobenzoyloxymethyl esters of 7 beta-[2-(2- aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3- methyl-3-cephem-4-carboxylic acid.
    Kakeya N; Nishimura K; Yoshimi A; Nakamura S; Nishizawa S; Tamaki S; Matsui H; Kawamura T; Kasai M; Kitao K
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):692-8. PubMed ID: 6547372
    [No Abstract]   [Full Text] [Related]  

  • 14. A new semisynthetic 7alpha-methoxycephalosporin, CS-1170: 7beta-((cyanomethyl)thio)acetamido)-7alpha-methoxy-3-((1-methyl-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid.
    Nakao H; Yanagisawa H; Shimizu B; Kaneko M; Nagano M
    J Antibiot (Tokyo); 1976 May; 29(5):554-8. PubMed ID: 956044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on orally active cephalosporin esters. IV. Effect of the C-3 substituent of cephalosporin on the gastrointestinal absorption in mice.
    Miyauchi M; Hirota T; Fujimoto K; Ide J
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3272-6. PubMed ID: 2632071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally active 2-(alkyloxycarbonyl)-2-alkylideneethyl esters of cephalosporins.
    Hubschwerlen C; Charnas R; Angehrn P; Furlenmeier A; Graser T; Montavon M
    J Antibiot (Tokyo); 1992 Aug; 45(8):1358-64. PubMed ID: 1399857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. II. Preparation of prodrugs.
    Kim WJ; Ko KY; Jung MH; Kim M; Lee KI; Kim JH
    J Antibiot (Tokyo); 1991 Oct; 44(10):1083-7. PubMed ID: 1955390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Orally active cephalosporins. I. Synthesis and structure-activity relationships of 7 beta-[2-(R)-amino-2-phenylacetamido]-3-(1H- 1,2,3-triazol-4-yl)alkylthiomethyl-3-cephem-4-carboxylic acid and related compounds].
    Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K
    Yakugaku Zasshi; 1992 Sep; 112(9):622-37. PubMed ID: 1469610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on beta-lactam antibiotics. III. Syntheses and antibacterial activities of new 3-(1,3-dithiolan-2-yl)cephalosporins, YM-22508, YM-16457 and their prodrug-type esters.
    Nagano N; Satoh M; Hara R
    J Antibiot (Tokyo); 1991 Apr; 44(4):422-8. PubMed ID: 2032951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on orally active cephalosporin esters. V. A prodrug approach for oral delivery of 3-thiazoliomethyl cephalosporin.
    Miyauchi M; Nakayama E; Fujimoto K; Kawamoto I; Ide J
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1906-10. PubMed ID: 2268893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.